Berger Tim, Fagu Albi, Czerny Martin, Hartikainen Tau, Von Zur Mühlen Constantin, Kueri Sami, Eschenhagen Matthias, Kreibich Maximilian, Beyersdorf Friedhelm, Rylski Bartosz
Department of Cardiovascular Surgery, University Heart Center, University Medical Center Freiburg, Freiburg, Germany.
University of Freiburg, Freiburg, Germany.
Thorac Cardiovasc Surg. 2024 Nov 4. doi: 10.1055/s-0044-1791960.
The aim of this study was to prospectively evaluate the feasibility and safety of intraoperative invasive coronary angiography (ICA) following coronary artery bypass grafting using a mobile angiography C-arm.
Between August 2020 and December 2021, 18 patients were enrolled for intraoperative ICA following coronary artery bypass grafting. After skin closure, ICA was performed including angiography of all established bypass grafts via a mobile angiography system by an interventional cardiologist. Data on graft patency, stenosis, and kinking were assessed. Grafts were rated on an ordinal scale ranging from very poor (1) to excellent (5). Furthermore, the impact of ICA compared with flow measurement was assessed using the ordinal Likert scale ranging from (I) worse to (V) much better.
The ICA was considered better (V) compared with transient flow measurement in 38 (93%) and comparable (III) in 3 (7%) distal anastomoses. ICA impacted clinical or surgical decision-making in three patients (17%). In one patient, dual antiplatelet therapy for 6 months was initiated and rethoracotomy was needed in two (11%) patients with bypass graft revision and additional bypass grafting for graft occlusion. There were no cerebral and distal embolic events or access vessel complications observed and no postoperative acute kidney injury occurred.
Intraoperative angiography after coronary bypass grafting is safe. Using a mobile angiographic device, graft patency, and function assessment was superior to transit time flow measurement leading to further consequences in a relevant number of patients. Therefore, it has the potential to reduce postoperative myocardial injury and improve survival.
本研究旨在前瞻性评估使用移动血管造影C型臂在冠状动脉旁路移植术后进行术中有创冠状动脉造影(ICA)的可行性和安全性。
在2020年8月至2021年12月期间,18例患者在冠状动脉旁路移植术后接受术中ICA。皮肤缝合后,由介入心脏病专家通过移动血管造影系统进行ICA,包括对所有已建立的旁路移植物进行血管造影。评估移植物通畅性、狭窄和扭结的数据。移植物按从非常差(1)到优秀(5)的顺序量表进行评分。此外,使用从(I)更差到(V)好得多的顺序李克特量表评估ICA与流量测量相比的影响。
在38例(93%)远端吻合术中,与瞬时流量测量相比,ICA被认为更好(V),3例(7%)相当(III)。ICA影响了3例患者(17%)的临床或手术决策。1例患者开始6个月的双联抗血小板治疗,2例(11%)患者因旁路移植物修复和因移植物闭塞进行额外旁路移植术而需要再次开胸。未观察到脑和远端栓塞事件或入路血管并发症,也未发生术后急性肾损伤。
冠状动脉旁路移植术后的术中血管造影是安全的。使用移动血管造影设备,移植物通畅性和功能评估优于通过时间流量测量,在相当数量的患者中产生了进一步的后果。因此,它有可能减少术后心肌损伤并提高生存率。